Levetiracetam 250 MG Oral Tablet
1 INDICATIONS AND USAGE Levetiracetam tablets are indicated for adjunctive therapy in the treatment of: Partial onset seizures in patients one month of age and older with epilepsy (1.1) Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3) 1.1 Partial Onset Seizures Levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam tablets are indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam tablets are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy.
Amneal Pharmaceuticals LLC
OVAL BLUE OL 250
Related Pills
Levetiracetam 1000 MG Oral Tablet
Amneal Pharmaceuticals LLC
Levetiracetam 750 MG Oral Tablet
Amneal Pharmaceuticals LLC
Levetiracetam 500 MG Oral Tablet
Amneal Pharmaceuticals LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
LEVETIRACETAM tablets, USP, 250 mg, are supplied as blue, oblong-shaped, scored, film-coated tablets debossed with “OL” and “250” on one side. They are supplied in white HDPE bottles and are available as follows: Bottles of 120: NDC 65162-528-16
LEVETIRACETAM tablets, USP, 500 mg, are supplied as yellow, oblong-shaped, scored, film-coated tablets debossed with “OL” and “500”on one side. They are supplied in white HDPE bottles and are available as follows: Bottles of 120: NDC 65162-529-16
LEVETIRACETAM tablets, USP, 750 mg, are supplied as dark pink, oblong-shaped, scored, film-coated tablets debossed with “OL” and “750” on one side. They are supplied in white HDPE bottles and are available as follows: Bottles of 120: NDC 65162-538-16
LEVETIRACETAM tablets, USP, 1,000 mg, are supplied as white, oblong-shaped, scored, film-coated tablets debossed with “OL” and “1000” on one side. They are supplied in white HDPE bottles and are available as follows: Bottles of 60: NDC 65162-539-06 16.2 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure.
More pills like OVAL OL 250